Liu Ray H, Liu Hsiu-Chuan, Lin Dong-Liang
Department of Forensic Toxicology, Institute of Forensic Medicine, Ministry of Justice, Taipei, Taiwan.
J Anal Toxicol. 2006 Oct;30(8):545-50. doi: 10.1093/jat/30.8.545.
With increasing requests for the analysis of various specimens related to fatal and non-fatal abuse of methylenedioxymethamphetamine (ecstasy, MDMA), the toxicology laboratory of the Institute of Forensic Medicine has established protocols for the analysis of MDMA and related compounds in hair, urine, and various postmortem specimens. Analytical protocols include extraction, derivatization, and gas chromatographic-mass spectrometric analysis adapting deuterated analogs of the analytes as internal standards. Data resulting from these analyses and hereby reported include postmortem distribution of MDMA and methylenedioxyamphetamine (MDA) in heart blood, gastric content, urine, and bile specimens from 20 fatal cases; other drugs found in the heart blood from these 20 cases; and the distribution of MDMA and MDA in 25 antemortem urine and 6 hair specimens. The MDA/MDMA concentration ratio observed in a limited number of hair specimens (n=6) are consistent and appear to be higher than those found in other specimens. Compared to other commonly abused drugs (e.g., cocaine and heroin), the "drug/metabolite" concentration ratio (MDMA/MDA) in hair is not significantly different from the ratios derived from other specimens, such as urine and blood. This observation is consistent with the relative drug/metabolite incorporation rates reported for cocaine/benzoylecgonine, tetrahydrocannabinol/tetrahydrocannabinoic acid, and MDMA/MDA.
随着对与亚甲基二氧甲基苯丙胺(摇头丸,MDMA)致命和非致命滥用相关的各种标本分析的需求不断增加,法医学研究所毒理学实验室已制定了在毛发、尿液和各种死后标本中分析MDMA及相关化合物的方案。分析方案包括提取、衍生化以及采用被分析物的氘代类似物作为内标进行气相色谱-质谱分析。这些分析得出并在此报告的数据包括20例致命病例的心血、胃内容物、尿液和胆汁标本中MDMA和亚甲基二氧苯丙胺(MDA)的死后分布;这20例病例心血中发现的其他药物;以及25份生前尿液和6份毛发标本中MDMA和MDA的分布。在数量有限的毛发标本(n = 6)中观察到的MDA/MDMA浓度比是一致的,且似乎高于在其他标本中发现的浓度比。与其他常见滥用药物(如可卡因和海洛因)相比,毛发中的“药物/代谢物”浓度比(MDMA/MDA)与尿液和血液等其他标本中的比值无显著差异。这一观察结果与报道的可卡因/苯甲酰爱康宁、四氢大麻酚/四氢大麻酸以及MDMA/MDA的相对药物/代谢物掺入率一致。